Basel Medical Group Ltd Ordinary Shares (BMGL) is a publicly traded Healthcare sector company. As of July 10, 2026, BMGL trades at $6.36 with a market cap of $9.74M and a P/E ratio of 0.00. BMGL moved +0.00% today. Year to date, BMGL is +12.59%; over the trailing twelve months it is -84.76%. Its 52-week range spans $4.60 to $112.80. Rallies surfaces BMGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Basel Medical Regains Nasdaq Compliance After Ten Consecutive $1 Closing Days: Basel Medical Group regained Nasdaq compliance after its ordinary shares met the minimum bid requirement for ten consecutive business days from June 23 to July 7, 2026. The company’s shares initially fell below the $1.00 threshold on January 22, 2026, triggering a deficiency notice and potential delisting risk.
| Metric | Value |
|---|---|
| Price | $6.36 |
| Market Cap | $9.74M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $112.80 |
| 52-Week Low | $4.60 |
| Volume | 2.83K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BMGL analyst coverage data. Average price target: $0.00.